Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
A low-cost point-of-care diagnostic for the detection of Neisseria gonorrhoeae and antibiotic resistant variants in resource-constrained settings
EF 2023-24
Résumé
There is a crucial need for diagnostic tools for sexually transmitted infections (STIs). Gonorrhoea, caused by 'Neisseria gonorrhoeae' (NG), is the second most common bacterial STI, with 87 million new cases yearly, primarily affecting low- and middle-income countries (LMICs). Concerns about drug resistance in NG, including resistance to last-line therapies, further complicate treatment options. Limited access to diagnostic tests in LMICs due to cost, electricity restrictions, and delays in patient sample transport underscores the need for a new diagnostic tool that detects NG and drug-resistant variants in resource-limited settings.
My research focuses on creating such a tool using a clustered regularly interspaced short palindromic repeat system, otherwise known as CRISPR. CRISPR is a powerful biological tool that can be engineered to detect specific genetic targets within disease-causing organisms. This system uses guide molecules to direct a protein to a target, leading to non-specific cutting of surrounding molecules upon detection. As a diagnostic tool, CRISPR is comparable to traditional diagnostics but with the benefit of being operable without electricity.
My project aims to develop a CRISPR-based sensor for identifying NG and predicting drug resistance. This involves designing, testing, and optimizing guide molecules to detect NG-specific targets and genetic mutations that promote drug resistance. My final sensor design will be implemented into a cost-effective lateral flow test, and its performance will be validated using various samples. This innovative project lays the groundwork for improved NG and drug resistance detection, offering a portable and affordable testing option for LMICs to guide treatment strategies and reduce the spread of NG.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506269
Name
Tse Kelvin
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
A low-cost point-of-care diagnostic for the detection of Neisseria gonorrhoeae and antibiotic resistant variants in resource-constrained settings
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antimicrobial Resistance; Bioinformatics; Biosensor; Crispr; Diagnostics; Infectious Disease; Lateral Flow; Low- Or Middle-Income Countries; Neisseria Gonorrhoeae; Self-Testing/ Point-Of-Care
Abstract
There is a crucial need for diagnostic tools for sexually transmitted infections (STIs). Gonorrhoea, caused by 'Neisseria gonorrhoeae' (NG), is the second most common bacterial STI, with 87 million new cases yearly, primarily affecting low- and middle-income countries (LMICs). Concerns about drug resistance in NG, including resistance to last-line therapies, further complicate treatment options. Limited access to diagnostic tests in LMICs due to cost, electricity restrictions, and delays in patient sample transport underscores the need for a new diagnostic tool that detects NG and drug-resistant variants in resource-limited settings.
My research focuses on creating such a tool using a clustered regularly interspaced short palindromic repeat system, otherwise known as CRISPR. CRISPR is a powerful biological tool that can be engineered to detect specific genetic targets within disease-causing organisms. This system uses guide molecules to direct a protein to a target, leading to non-specific cutting of surrounding molecules upon detection. As a diagnostic tool, CRISPR is comparable to traditional diagnostics but with the benefit of being operable without electricity.
My project aims to develop a CRISPR-based sensor for identifying NG and predicting drug resistance. This involves designing, testing, and optimizing guide molecules to detect NG-specific targets and genetic mutations that promote drug resistance. My final sensor design will be implemented into a cost-effective lateral flow test, and its performance will be validated using various samples. This innovative project lays the groundwork for improved NG and drug resistance detection, offering a portable and affordable testing option for LMICs to guide treatment strategies and reduce the spread of NG.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tse, Kelvin
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~